Cargando…

Meta-analysis of liver injury in patients with COVID-19

The coronavirus disease 2019 (COVID-19) is a major public health problem threatening human health. It can lead to multiple system complications, among which liver damage is also a common complication of COVID-19. The pathogenesis of liver injury is complex and involves the interaction of multiple fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinghai, Fan, Caiping, Tang, Jin, Zhang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662882/
https://www.ncbi.nlm.nih.gov/pubmed/37478243
http://dx.doi.org/10.1097/MD.0000000000034320
_version_ 1785138295082057728
author Li, Xinghai
Fan, Caiping
Tang, Jin
Zhang, Ning
author_facet Li, Xinghai
Fan, Caiping
Tang, Jin
Zhang, Ning
author_sort Li, Xinghai
collection PubMed
description The coronavirus disease 2019 (COVID-19) is a major public health problem threatening human health. It can lead to multiple system complications, among which liver damage is also a common complication of COVID-19. The pathogenesis of liver injury is complex and involves the interaction of multiple factors. This study aims to investigate the incidence and risk factors of liver injury in COVID-19 patients and analyze the impact of liver injury on clinical prognosis of patients, so as to provide corresponding basis for clinical diagnosis and treatment. METHODS: PubMed and Cochrane Library were searched in computer to collect original studies on liver injury cases, laboratory indicators and clinical outcomes in COVID-19 patients. Articles were screened according to inclusion and exclusion criteria, and data were meta-analyzed using Stata12.0 software. RESULTS: A total of 49 studies, including 23,611 patients with COVID-19, had a prevalence of liver injury of 39.63%. Subgroup analysis found that patients in the Americas had the highest incidence of liver injury at 43.7% and lowest in Africa (25.99%). The vast majority of liver injury is manifested by aminotransferase or bilirubin levels greater than 1 times the upper limit of normal (49.16%). The older the age, the male, the associated chronic liver disease, and the higher the levels of white blood cells, neutrophils, and C-reactive protein, the higher the risk of liver injury. The use of hormones, hydroxychloroquine, and tocilizumab increases the risk of liver injury. Patients with concurrent liver injury have longer hospital stays, are more likely to progress to severe cases, and have a higher risk of death than patients without liver injury. CONCLUSION: The incidence of liver injury in COVID-19 patients was high, affected by age, gender, chronic liver disease, inflammatory state and medication, and patients with liver injury were hospitalized longer and were more likely to have a poor prognosis. Therefore, clinical attention should be paid to early intervention.
format Online
Article
Text
id pubmed-10662882
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106628822023-07-21 Meta-analysis of liver injury in patients with COVID-19 Li, Xinghai Fan, Caiping Tang, Jin Zhang, Ning Medicine (Baltimore) 6600 The coronavirus disease 2019 (COVID-19) is a major public health problem threatening human health. It can lead to multiple system complications, among which liver damage is also a common complication of COVID-19. The pathogenesis of liver injury is complex and involves the interaction of multiple factors. This study aims to investigate the incidence and risk factors of liver injury in COVID-19 patients and analyze the impact of liver injury on clinical prognosis of patients, so as to provide corresponding basis for clinical diagnosis and treatment. METHODS: PubMed and Cochrane Library were searched in computer to collect original studies on liver injury cases, laboratory indicators and clinical outcomes in COVID-19 patients. Articles were screened according to inclusion and exclusion criteria, and data were meta-analyzed using Stata12.0 software. RESULTS: A total of 49 studies, including 23,611 patients with COVID-19, had a prevalence of liver injury of 39.63%. Subgroup analysis found that patients in the Americas had the highest incidence of liver injury at 43.7% and lowest in Africa (25.99%). The vast majority of liver injury is manifested by aminotransferase or bilirubin levels greater than 1 times the upper limit of normal (49.16%). The older the age, the male, the associated chronic liver disease, and the higher the levels of white blood cells, neutrophils, and C-reactive protein, the higher the risk of liver injury. The use of hormones, hydroxychloroquine, and tocilizumab increases the risk of liver injury. Patients with concurrent liver injury have longer hospital stays, are more likely to progress to severe cases, and have a higher risk of death than patients without liver injury. CONCLUSION: The incidence of liver injury in COVID-19 patients was high, affected by age, gender, chronic liver disease, inflammatory state and medication, and patients with liver injury were hospitalized longer and were more likely to have a poor prognosis. Therefore, clinical attention should be paid to early intervention. Lippincott Williams & Wilkins 2023-07-21 /pmc/articles/PMC10662882/ /pubmed/37478243 http://dx.doi.org/10.1097/MD.0000000000034320 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle 6600
Li, Xinghai
Fan, Caiping
Tang, Jin
Zhang, Ning
Meta-analysis of liver injury in patients with COVID-19
title Meta-analysis of liver injury in patients with COVID-19
title_full Meta-analysis of liver injury in patients with COVID-19
title_fullStr Meta-analysis of liver injury in patients with COVID-19
title_full_unstemmed Meta-analysis of liver injury in patients with COVID-19
title_short Meta-analysis of liver injury in patients with COVID-19
title_sort meta-analysis of liver injury in patients with covid-19
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662882/
https://www.ncbi.nlm.nih.gov/pubmed/37478243
http://dx.doi.org/10.1097/MD.0000000000034320
work_keys_str_mv AT lixinghai metaanalysisofliverinjuryinpatientswithcovid19
AT fancaiping metaanalysisofliverinjuryinpatientswithcovid19
AT tangjin metaanalysisofliverinjuryinpatientswithcovid19
AT zhangning metaanalysisofliverinjuryinpatientswithcovid19